Menu
Back to User profile » Prof. Dr. Peter Alter
Papers published by Prof. Dr. Peter Alter:
Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET
Alter P, Stoleriu C, Kahnert K, Henke MO, Bals R, Trudzinski FC, Watz H, Speicher T, Söhler S, Welte T, Rabe KF, Wouters EFM, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2911-2923
Published Date: 6 December 2023
Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
Alter P, Kahnert K, Trudzinski FC, Bals R, Watz H, Speicher T, Söhler S, Andreas S, Welte T, Rabe KF, Wouters EFM, Sassmann-Schweda A, Wirtz H, Ficker JH, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1703-1713
Published Date: 29 July 2022
Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET
Fischer C, Jörres RA, Alter P, Trudzinski FC, Yildirim, Bals R, Vogelmeier CF, Kauffmann-Guerrero D, Behr J, Watz H, Holle R, Kahnert K
Patient Preference and Adherence 2022, 16:1759-1770
Published Date: 26 July 2022
Differences in the Measurement of Functional Residual Capacity Between Body Plethysmographs of Two Manufacturers
Alter P, Orszag J, Wouters EF, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1477-1482
Published Date: 24 June 2022
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
Kahnert K, Jörres RA, Lucke T, Trudzinski FC, Mertsch P, Bickert C, Ficker JH, Behr J, Bals R, Watz H, Welte T, Vogelmeier CF, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3189-3199
Published Date: 24 November 2021
Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
Lutter JI, Jörres RA, Trudzinski FC, Alter P, Kellerer C, Watz H, Welte T, Bals R, Kauffmann-Guerrero D, Behr J, Holle R, Vogelmeier CF, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:987-998
Published Date: 14 April 2021
Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
Lutter JI, Jörres RA, Welte T, Watz H, Waschki B, Alter P, Trudzinski FC, Ohlander J, Behr J, Bals R, Studnicka M, Holle R, Vogelmeier CF, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2787-2798
Published Date: 5 November 2020
Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD
Andreas S, McGarvey L, Bothner U, Trampisch M, de la Hoz A, Fležar M, Buhl R, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1935-1944
Published Date: 10 August 2020
No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD
Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1945-1953
Published Date: 10 August 2020
A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1955-1965
Published Date: 10 August 2020
Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K
Patient Preference and Adherence 2019, 13:1711-1721
Published Date: 10 October 2019
Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
Alter P, Mayerhofer BA, Kahnert K, Watz H, Waschki B, Andreas S, Biertz F, Bals R, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2163-2172
Published Date: 20 September 2019
Personalized medicine for patients with COPD: where are we?
Franssen FME, Alter P, Bar N, Benedikter BJ, Iurato S, Maier D, Maxheim M, Roessler FK, Spruit MA, Vogelmeier CF, Wouters EFM, Schmeck B
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1465-1484
Published Date: 9 July 2019
Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
Greulich T, Mager S, Lucke T, Koczulla AR, Bals R, Fähndrich S, Jörres RA, Alter P, Kirsten A, Vogelmeier CF, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2999-3002
Published Date: 28 September 2018
Influence of body mass on predicted values of static hyperinflation in COPD
Alter P, Rabe KF, Schulz H, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2551-2555
Published Date: 23 August 2018
COPD as a risk factor of the complications in lower limb arthroplasty: a patient-matched study
Klasan A, Dworschak P, Heyse TJ, Ruchholtz S, Alter P, Vogelmeier C, Schwarz Patrick
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2495-2499
Published Date: 21 August 2018